CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Kowa Pharmaceuticals America recalls Livalo (pitavatstatin) tablets

Read the official FDA notice

Published
19 Mar 2025
Units affected
5,328 Bottles
Agency
FDA
Country
United States

The hazard

Presence of foreign tablets/capsules

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90 HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case

Brand / company
Kowa Pharmaceuticals America
Codes / lots
Lot#: 3231300, Exp 8/2027
Distribution
PA, OH, and TX
Recall status
Completed

Source: U.S. Food and Drug Administration, published 19 Mar 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.